UnitedHealth Group (NYSE: UNH) exceeded earnings expectations with adjusted EPS of $2.92, beating the consensus of $2.82. However, revenue fell short at $113.2B compared to the expected $114.19B, with operating income down 50% year-over-year. Despite this, shares rose 4.17% pre-market. The company’s insurance unit, UnitedHealthcare, saw a 16% increase in revenue to $87.1B, while the health services and technology division, Optum, grew by 8% to $69.2B. Managing medical cost trends and Medicare funding reductions are ongoing challenges, with pricing power remaining constrained. Management raised full-year 2025 guidance, signaling confidence in future growth.

In summary, UnitedHealth Group beat earnings expectations on adjusted EPS but fell short on revenue. Despite a decline in operating income, UnitedHealthcare saw significant revenue growth while Optum’s growth is slowing. The company faces challenges with medical costs and Medicare funding reductions, leading to constrained pricing power. Management remains cautiously optimistic, raising full-year guidance for 2025 and focusing on future growth and performance beyond the current year.

Read more at Yahoo Finance: United Health Jumps After Big Q3 Earnings